"About The Vascular Experts Founded in 2001 to deliver expert vascular medical and surgical care to the communities of Connecticut and Rhode Island, we are the largest group of Board-certified vascular surgeons in the nation, with state-of-the-art facilities in multiple locations. For the comfort, convenience and improved health of our patient, The Vascular Experts perform essential procedures on-site, including angioplasty, endovascular surgery, sclerotherapy and minimally invasive surgical procedures, using the latest medical technology and modern endovascular therapies, as well as traditional procedures for treatment of vascular disease."

During the past decade, The Vascular Experts conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Vascular Experts" #1 sponsor was "PQ Bypass, Inc." with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "Cook Research Incorporated" with 1 trials sponsored, "Humacyte, Inc." with 1 trials sponsored and "Intervene, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Vascular Experts" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Vascular Experts" are "Peripheral Arterial Disease" (2 trials), "Chronic Venous Insufficiency" (1 trials), "Chronic Venous Insufficiency (CVI)" (1 trials), "Deep Vein Reflux" (1 trials) and "Deep Vein Thrombosis" (1 trials). Many other conditions were trialed in "The Vascular Experts" in a lesser frequency.

Most popular intervention types in "The Vascular Experts" are "Device" (7 trials), "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abre venous self-expanding stent system" (1 trials), "Arteriovenous fistula (AVF)" (1 trials), "BlueLeaf® Endovenous Valve Formation System (BlueLeaf System)" (1 trials), "ClariVein RES" (1 trials) and "Conventional angioplasty balloon catheters" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Vascular Experts" are 9 trials for "All" genders.

Currently, there are NaN active trials in "The Vascular Experts". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Vascular Experts, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Vascular Experts, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".